VICTORIA, British Columbia (AP) _ Aurinia Pharmaceuticals Inc. (AUPH) on Thursday reported a loss of $18.3 million in its third quarter.
The Victoria, British Columbia-based company said it had a loss of 21 cents per share.
The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.
The biotechnology company posted revenue of $375,000 in the period.
Aurinia shares have climbed 24 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $5.60, a fall of almost 3 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AUPH at https://www.zacks.com/ap/AUPH